Condition: PARKINSON DISEASE (Disorder) · Advanced Parkinson's Disease · Sponsor: Serina Therapeutics
This is a randomized, placebo-controlled, single ascending dose (SAD) study of SER-252 in participants with Parkinson's Disease (PD) and motor fluctuations.
This description comes directly from the study's public registry record.
Randall Moreadith, MD, PhD · (256) 783-7649 · rmoreadith@serinatherapeutics.com
Always discuss trial participation with your own doctor first.
| Rocky Mountain Clinical Research | Englewood, Colorado, United States | Not Yet Recruiting |
| Velocity Clinical Research | Hallandale, Florida, United States | Recruiting |
| K2 Medical Research LLC | Maitland, Florida, United States | Recruiting |
| Quest Research Institute | Farmington Hills, Michigan, United States | Recruiting |
| CMAX | Adelaide, South Australia, Australia | Recruiting |
| Monash | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07422675